Combination Chemotherapy With or Without Oregovomab Followed By Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by University of Nebraska
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Chi Lin, MD, University of Nebraska
ClinicalTrials.gov Identifier:
NCT01959672
First received: October 8, 2013
Last updated: July 1, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)